The Associate Dean for Scientific Affairs obtains a patent within a research team from Babylon and University of Technology

Patented

The Central Organization for Standardization and Quality Control of the Ministry of Planning granted a patent to a joint working group of Karbala, Babylon and Technology Universities, No. (6895) on 4/11/2021, tagged with the title “Preparation of new joint homogeneous medicinal polymers (sulfadiazine and paracetamol) from malinamide as a carrier system. of the drug and the study of its efficacy against breast cancer.

Where the research team was able to prepare new homogeneous co-polymers (sulfadiazine and paracetamol) from maleinamide. The patent also includes identifying how these polymers can be used as a drug transport system and studying their effectiveness against breast cancer. The head of the research team, Prof. Dr. Muhammad Nazem Al-Bayati / Department of Chemistry / College of Education for Pure Sciences / University of Karbala, said that the team consisted of:

Prof. Dr. Muhammad Nazem Bahjat, University of Karbala/College of Education for Pure Sciences/Department of Chemistry
A.M.D. Muhannad Musa Karim University of Babylon/College of Science/Department of Chemistry
Prof. Maged Dhahi Jaber University of Technology/Department of Applied Sciences
Lect. Fatima Abdul-Razzaq Majid, University of Karbala/College of Education for Pure Sciences/Department of Chemistry

The Associate Dean for Scientific Affairs obtains a patent within a research team from Babylon and University of Technology

Patented

The Central Organization for Standardization and Quality Control of the Ministry of Planning granted a patent to a joint working group of Karbala, Babylon and Technology Universities, No. (6895) on 4/11/2021, tagged with the title “Preparation of new joint homogeneous medicinal polymers (sulfadiazine and paracetamol) from malinamide as a carrier system. of the drug and the study of its efficacy against breast cancer.
Where the research team was able to prepare new homogeneous co-polymers (sulfadiazine and paracetamol) from maleinamide. The patent also includes identifying how these polymers can be used as a drug transport system and studying their effectiveness against breast cancer. The head of the research team, Prof. Dr. Muhammad Nazem Al-Bayati / Department of Chemistry / College of Education for Pure Sciences / University of Karbala, said that the team consisted of:
Prof. Dr. Muhammad Nazem Bahjat, University of Karbala/College of Education for Pure Sciences/Department of Chemistry
A.M.D. Muhannad Musa Karim University of Babylon/College of Science/Department of Chemistry
Prof. Maged Dhahi Jaber University of Technology/Department of Applied Sciences
Lect. Fatima Abdul-Razzaq Majid, University of Karbala/College of Education for Pure Sciences/Department of Chemistry